Bronchitis

Avelox shows clinical success for acute exacerbations of chronic bronchitis

Published in Women's Health Weekly, April 8th, 2004

A new study shows patients with acute exacerbations of chronic bronchitis (AECB) who took a 5-day course of the antibiotic Avelox (moxifloxacin HCl) achieved a greater clinical cure rate than patients who took a 7-day course of the antibiotics most commonly prescribed to treat AECB, such as clarithromycin, amoxicillin, and cefuroxime-axetil.

The results of the MOSAIC study, a major clinical trial, were published in the March issue of Chest, the peer-reviewed journal of the American College of Chest Physicians.

In the MOSAIC study, clinical success was defined as the resolution or improvement of all AECB signs and symptoms, which include the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2004-04-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry